Eventide Asset Management, LLC / 2655787D
Eventide Asset Management, LLC’s Blueprint Medicines Position
Does Eventide Asset Management, LLC own Blueprint Medicines (2655787D)? Not currently — the last reported position was 728.8K shares worth $93M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$93M
Q2 2025
Shares
728.8K
% of Portfolio
+1.64%
Quarters Held
27
position exited
Position History 2655787D
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2025 | 728.8K | $93M | +1.64% |
| Q1 2025 | 862.5K | $76M | +1.52% |
| Q4 2024 | 862.3K | $75M | +1.37% |
| Q3 2024 | 348.7K | $32M | +0.56% |
| Q2 2024 | 231.7K | $25M | +0.43% |
| Q1 2024 | 231.7K | $22M | +0.34% |
| Q4 2023 | 312.4K | $29M | +0.47% |
| Q3 2023 | 438.5K | $22M | +0.40% |
| Q2 2023 | 438.5K | $28M | +0.47% |
| Q1 2023 | 438.5K | $20M | +0.36% |
| Q4 2022 | 438.5K | $19M | +0.38% |
| Q3 2022 | 438.5K | $29M | +0.57% |
| Q2 2022 | 438.5K | $22M | +0.47% |
| Q1 2022 | 592.5K | $38M | +0.59% |
| Q4 2021 | 395.8K | $42M | +0.54% |
| Q3 2021 | 356.0K | $37M | +0.48% |
| Q2 2021 | 461.7K | $41M | +0.55% |
| Q1 2021 | 462.0K | $45M | +0.67% |
| Q4 2020 | 462.0K | $52M | +0.79% |
| Q3 2020 | 462.0K | $43M | +0.84% |
| Q2 2020 | 462.0K | $36M | +0.78% |
| Q1 2020 | 462.0K | $27M | +0.87% |
| Q4 2019 | 462.0K | $37M | +1.04% |
| Q3 2019 | 462.0K | $34M | +1.12% |
| Q2 2019 | 462.0K | $44M | +1.32% |
| Q1 2019 | 462.0K | $37M | +1.27% |
| Q4 2018 | 412.0K | $22M | +0.98% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Eventide Asset Management, LLC’s full portfolio or all institutional holders of 2655787D.